Bryn Mawr Capital Management LLC Increases Holdings in STERIS plc (NYSE:STE)

Bryn Mawr Capital Management LLC boosted its holdings in STERIS plc (NYSE:STE) by 129.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,925 shares of the medical equipment provider’s stock after purchasing an additional 1,085 shares during the period. Bryn Mawr Capital Management LLC’s holdings in STERIS were worth $396,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of STE. Franklin Resources Inc. raised its position in STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Boston Trust Walden Corp increased its stake in shares of STERIS by 400.4% in the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock worth $46,198,000 after acquiring an additional 179,829 shares in the last quarter. Swedbank AB bought a new position in shares of STERIS during the third quarter valued at approximately $28,251,000. Benjamin Edwards Inc. increased its position in STERIS by 2,123.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider’s stock valued at $27,574,000 after buying an additional 108,559 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of STERIS by 9.5% in the 3rd quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider’s stock worth $270,230,000 after purchasing an additional 96,336 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Trading Down 1.4 %

Shares of STE stock opened at $219.89 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $21.60 billion, a price-to-earnings ratio of 46.69 and a beta of 0.84. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The stock’s 50-day moving average price is $214.45 and its 200-day moving average price is $223.13.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.04%. STERIS’s payout ratio is currently 48.41%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on STE shares. Stephens restated an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, November 8th. Finally, Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.